Nanologica AB

4YD

Company Profile

  • Business description

    Nanologica AB is a Swedish life science tools company that develops, manufactures, and sells key consumables to pharmaceutical manufacturers. Its products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, it can increase productivity and reduce costs for pharmaceutical manufacturers. The group operates in a world-wide niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company's mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments.

  • Contact

    Forskargatan 20 G
    Sodertalje151 36
    SWE

    T: +46 841074949

    https://www.nanologica.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    72

Stocks News & Analysis

stocks

ASX share undervalued as margins expected to rebound

This ASX share remains overlooked despite a strong outlook.
stocks

Cheap retail REIT with an attractive yield

Lower consumer spending unlikely to buckle this retail REIT.
stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,177.8062.100.68%
CAC 408,447.2763.260.75%
DAX 4024,910.4116.400.07%
Dow JONES (US)51,999.67328.640.64%
FTSE 10010,494.2163.590.61%
HKSE24,402.7191.24-0.37%
NASDAQ26,376.34307.60-1.15%
Nikkei 22569,935.27530.770.76%
NZX 50 Index13,410.5215.61-0.12%
S&P 5007,511.3542.94-0.57%
S&P/ASX 2008,960.3059.500.67%
SSE Composite Index4,078.3313.56-0.33%

Market Movers